Filing Details

Accession Number:
0001127602-24-012998
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-04-16 16:32:18
Reporting Period:
2024-04-12
Accepted Time:
2024-04-16 16:32:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1531048 Inari Medical Inc. NARI Surgical & Medical Instruments & Apparatus (3841) 452902923
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1644989 Hill, Mitch C. C/O Inari Medical, Inc.
6001 Oak Canyon
Irvine CA 92618
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-04-12 6,000 $0.46 187,294 No 4 M Direct
Common Stock Disposition 2024-04-12 6,000 $40.96 181,294 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2024-04-12 6,000 $0.00 6,000 $0.46
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
82,477 2029-04-23 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,600 Indirect By Spouse
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2023.
  2. This transaction was executed in multiple trades at prices ranging from $40.54 to $41.53. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. Options vested with respect to 25% of the shares on April 30, 2020 and vested with respect to the remaining shares in 36 equal monthly installments thereafter.